Jones Financial Companies
CTSO icon

Jones Financial Companies’s Cytosorbents Corp CTSO Stock Holding History

Jones Financial Companies’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-93
Closed -$55 – 5014
2026
Q1 		$55 Hold
93
– – ﹤0.01% 4667
2025
Q4 		$59 Sell
93
-500
-84% -$385 ﹤0.01% 4335
2025
Q3 		$553 Buy
+593
New +$584 ﹤0.01% 4027

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jones Financial Companies's CTSO Position: Q2 2026 in Review

Jones Financial Companies sold out of Cytosorbents Corp (CTSO) in Q2 2026, closing a stake of 93 shares — an estimated $55 sold.

Jones Financial Companies first reported a position in CTSO in Q3 2025 and held it in 3 quarters. The position peaked at $553 in Q3 2025. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Jones Financial Companies reported no remaining Cytosorbents Corp position as of Q2 2026 after selling out during the quarter.
  • Jones Financial Companies sold 93 Cytosorbents Corp shares in Q2 2026, an estimated $55.
  • Jones Financial Companies first reported a position in Cytosorbents Corp in Q3 2025 and held it in 3 quarters.
  • Jones Financial Companies's Cytosorbents Corp position peaked at $553 in Q3 2025.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.